AVTX compared with LBRX: revenue, margins and what each company keeps, and the suppliers and customers both name

AVTXAvalo Therapeutics, Inc.

Mkt capRevenueRevenue

LBRXLB Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

AVTXAvalo Therapeutics, Inc.

LBRXLB Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AVTX 5

LLYEli Lillysupplier

JNJJanssen Pharmaceutics, Inc., now Johnson & Johnson Innovative Medicine ("J&J")customer

—Leap Therapeuticsunlistedsupplier

—AlmataBiounlistedsupplier

1 more · AVTX chain ›

Shared 0

No disclosed counterparties: LBRX.

Only LBRX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AVTXAvalo Therapeutics, Inc.

6.64▼−6.12%· post 6.64· delayed

Mkt cap$379.2MRevenue$59,000Q4 FY25

LBRXLB Pharmaceuticals Inc

38.72▼−5.23%· post 38.66· delayed

After hoursNov 5 '26delayed

Mkt cap$1.2BRevenue—

Compare

After hoursNov 5 '26delayed

AVTXAvalo Therapeutics, Inc.

LBRXLB Pharmaceuticals Inc

6.64▼−6.12%post 6.64delayed

Price

38.72▼−5.23%post 38.66delayed

$379.2M

Mkt cap

$1.2B

Q4 FY25$59,000

Revenue

—

AVTX6.64▼−6.12%vsLBRX38.72▼−5.23%After hoursNov 5 '26delayed